Some links on this page are affiliate links. If you buy through them, SynergyStacks may earn a commission at no extra cost to you. This never changes how we grade evidence. Educational information only — not medical advice.
MAKE IT.DON'T LOSEIT.
Cistanche raised LH and testosterone in rats, through the brain's GnRH signal. Eurycoma has human trials showing higher testosterone and lab evidence that it inhibits aromatase. One idea makes the signal, the other limits the loss. But the human evidence is limited, the combination has never been tested, and we grade this stack accordingly.
VIEW CISTANCHE →The
mechanism.
Signals the brain
In rat studies, Cistanche extract raised LH and testosterone, with authors attributing it to increased hypothalamic GnRH secretion. Rodent data only.
Blocks the loss
Eurycomanone from Eurycoma longifolia inhibited aromatase (the enzyme converting testosterone to estradiol) in lab work, and Eurycoma extracts raised testosterone in human trials. Evidence quality varies — see the notes below.
Signal + retention
The hypothesis: one raises the production signal, the other reduces conversion to estrogen. Never tested as a combination in a controlled study.
What we
know.
Cistanche tubulosa ethanol extract mediates rat sex hormone levels by induction of testicular steroidogenic enzymes
Extract increased serum testosterone, LH, and FSH in non-castrated male rats; the authors suggest a central mechanism via GnRH. Rodent model — not human data.
https://pubmed.ncbi.nlm.nih.gov/26004585/The role of Cistanches Herba and its ingredients in improving reproductive outcomes: A comprehensive review
Review of bioactive compounds (echinacoside, verbascoside, salidroside) and effects on gonadal function. The review notes high-quality clinical studies are required.
https://pubmed.ncbi.nlm.nih.gov/38718638/Eurycoma longifolia (Jack) Improves Serum Total Testosterone in Men: A Systematic Review and Meta-Analysis of Clinical Trials
Meta-analysis reporting higher total testosterone with Eurycoma supplementation. Note: publication bias and industry funding were flagged.
https://doi.org/10.3390/medicina58081047Effect of Eurycoma longifolia standardised aqueous root extract (Physta®) on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study
RCT in older men with low testosterone; 200 mg/day for 12 weeks reported to raise total testosterone vs. placebo. Likely industry-funded — check funding and numbers in the paper before quoting.
https://doi.org/10.29219/fnr.v65.5647Standardised water-soluble extract of Eurycoma longifolia, Tongkat ali, as testosterone booster for managing men with late-onset hypogonadism?
Open-label study (no placebo group) of 200 mg standardized extract for one month in men with late-onset hypogonadism, reporting higher testosterone and symptom scores. Weaker design than an RCT.
https://doi.org/10.1111/j.1439-0272.2011.01168.xEurycomanone, the major quassinoid in Eurycoma longifolia root extract increases spermatogenesis by inhibiting the activity of phosphodiesterase and aromatase in steroidogenesis
Eurycomanone inhibited aromatase and phosphodiesterase activity in lab models. This is the mechanistic basis for the "less conversion to estrogen" idea — not a direct human measurement.
https://doi.org/10.1016/j.jep.2013.06.023Correlation between serum zinc and testosterone: A systematic review
Zinc deficiency is linked to lower testosterone and supplementation helps mainly in zinc-deficient people.
https://doi.org/10.1016/j.jtemb.2022.127103Association between vitamin D and testosterone levels: a systematic review and meta-analysis
Vitamin D deficiency is associated with lower testosterone; supplementation appears to matter mainly in deficient people.
https://doi.org/10.1111/cen.13254Two elements.
One mode.
GnRH
signaling
aromatase
inhibitor
The Eurycoma Physta® trial (105 men, 12 weeks, double-blind) is the strongest human evidence in this stack — and it is about Eurycoma alone. Cistanche has promising animal data but no human RCT with testosterone as the primary outcome.
The combination has never been tested in a single study. The synergy is hypothesized from mechanisms, not demonstrated.
Eurycoma: Chinnappan S.M. et al., Food Nutr Res. 2021;65. PMID: 34262417. https://doi.org/10.29219/fnr.v65.5647
Questions.
Answered.
No. Eurycoma has several human studies showing testosterone increases (with caveats about design and funding). Cistanche has animal data and no human testosterone RCT. The combination has never been tested.
We grade it as a Mechanism Preview.
Two different points of the same pathway:
Cistanche — in rats, raised hypothalamic GnRH signaling and downstream LH, the signal that drives testosterone production.
Eurycoma — in lab work, inhibited aromatase, the enzyme that converts testosterone to estradiol.
They are the foundation: deficiency in either can lower testosterone, and supplementation helps mainly if you are deficient.
Zinc: helps only if you are low. Vitamin D: supplementation helps mainly when blood levels are low. Get them tested before buying anything else.
Probably not a priority. If your labs are normal and you feel fine, the likely benefit is small.
If you have symptoms of low testosterone (fatigue, low libido, poor recovery) and labs confirm it, talk to a doctor before self-treating with supplements.
Choose your
format.
Cistanche
Tongkat Ali (Eurycoma)
Last reviewed: